NIAID Site Search

As global temperatures rise, it has become more urgent to understand the interactions between climate, mosquitoes, and the pathogens mosquitoes transmit to humans. NIAID Now spoke to Luis Chaves, Ph.D., a 2023 Scholar with the National Institutes of Health (NIH) Climate Change and Health Initiative, about his work about the impacts of environmental change on the ecology of insect vectors and the diseases they transmit.

Published: August 18, 2023

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Olivia Steele-Mortimer, Ph.D., is Deputy Chief of the Laboratory of Bacteriology and Chief of the Salmonella-Host Cell Interactions Section. Salmonella enterica serovar Typhimurium (S. Typhimurium) is a common cause of gastroenteritis in humans. Our group studies how S. Typhimurium interacts with mammalian cells.

Last Reviewed: July 12, 2022

Two U.S. Food and Drug Administration (FDA)–approved mRNA vaccines for COVID-19 have saved millions of lives. These vaccines were developed with NIH support and research on a protein found on SARS-CoV-2, the virus that causes COVID-19. Clinical trials for the COVID-19 vaccines in people were established in what seemed like record time. But in reality, more than 50 years of public and private

Last Reviewed: April 4, 2024

Candida auris, is an emerging healthcare-associated infection of growing public health concern. NIAID supports several researchers who are asking fundamental questions about the biology of C. auris. Today’s NIAID Now post features insights from NIAID-funded researchers, Jeniel Nett, M.D., Ph.D., associate professor of medicine and medical microbiology and immunology at University of Wisconsin-Madison, and Christina Cuomo, Ph.D., associate director of the Genomic Center of Infectious Diseases at the Broad Institute of Massachusetts Institute of Technology and Harvard University.

Published: September 23, 2022

Tongqing Zhou, Ph.D. is the Chief of the Structural Virology and Vaccinology Section (SVVS). SVVS seeks to apply structural biology to the development of an effective HIV-1 vaccine. Despite the enormous potential of atomic-level design—successfully used, for example, in the development of potent drugs against the HIV-1 protease—current vaccine development makes little use of atomic-level information. We are trying to change this.

Last Reviewed: March 19, 2025

We study how Salmonella Typhimurium interacts with mammalian host cells and the roles these interactions play in pathogenesis.

Last Reviewed: September 28, 2022

Innovative Drug Delivery for Spinal Cord Injury: NurExone's Exosome-Based siRNA Therapy with FDA Endorsement and Expanding Pipeline for Neuronal Regeneration November 14, 2024 Presenter: Dr. Lior Shaltiel, CEO, NurExone Biologic Inc. NurExone is leading the advancement of drug delivery systems for CNS indications and specially in spinal cord injury treatment. Their cutting-edge exosome-based siRNA

Last Reviewed: November 13, 2024

Role of vector saliva in blood feeding by arthropods, in particular determining the structure-function relationships of their components.

Last Reviewed: September 27, 2022

The 206 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Tuesday, January 30, 2024. Dr. Jeanne Marrazzo, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:45 a.m. and from 1

Last Reviewed: May 21, 2024